Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

Hybrid Nanoplex Vaccines: Harnessing Bacterial Vesicle Adjuvancy with mRNA Antigen Delivery for Advanced Melanoma.

FY 2025-26

Summary
Melanoma is an aggressive form of skin cancer that can spread throughout the body, making it difficult to treat. Although therapies such as immune checkpoint inhibitors have improved survival for some patients, nearly half do not respond because they fail to generate a strong enough immune response. Our research aims to develop a new form of cancer vaccine that combines two powerful applications into a single hybrid system. The proposed system will integrate bacterial extracellular vesicles, which are tiny particles naturally released by bacteria and strongly stimulate the immune system, and mRNA-loaded nanoparticles, which carry genetic instructions to produce cancer-specific proteins. By uniting these components into one therapeutic system, the vaccine is designed to stimulate the immune system and direct it to precisely target melanoma cells. We will evaluate our approach in laboratory and animal models to assess its ability to reduce tumour growth, prevent cancer spread, and enhance the effects of existing therapies. If successful, our hybrid system could establish a new treatment pathway for advanced, resistant melanoma, with the potential to improve patient survival and quality of life.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
560261
Name
Schutt Danielle J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Hybrid Nanoplex Vaccines: Harnessing Bacterial Vesicle Adjuvancy with mRNA Antigen Delivery for Advanced Melanoma.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Animal Models; Bacterial-Based Immunotherapy; Cancer Treatment; Immune Checkpoint Inhibitors; Melanoma; Mrna Delivery; Nanotechnology; Therapeutic Vaccines
Abstract
Melanoma is an aggressive form of skin cancer that can spread throughout the body, making it difficult to treat. Although therapies such as immune checkpoint inhibitors have improved survival for some patients, nearly half do not respond because they fail to generate a strong enough immune response. Our research aims to develop a new form of cancer vaccine that combines two powerful applications into a single hybrid system. The proposed system will integrate bacterial extracellular vesicles, which are tiny particles naturally released by bacteria and strongly stimulate the immune system, and mRNA-loaded nanoparticles, which carry genetic instructions to produce cancer-specific proteins. By uniting these components into one therapeutic system, the vaccine is designed to stimulate the immune system and direct it to precisely target melanoma cells. We will evaluate our approach in laboratory and animal models to assess its ability to reduce tumour growth, prevent cancer spread, and enhance the effects of existing therapies. If successful, our hybrid system could establish a new treatment pathway for advanced, resistant melanoma, with the potential to improve patient survival and quality of life.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schutt, Danielle J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~